Health care is rapidly changing, and direct-to-patient testing is becoming more affordable and accessible. At this year’s Individualizing Medicine Conference, attendees will receive an inside look into how Mayo Clinic is connecting and accessing biospecimens from study design to clinical integration.
In addition to increased access to multi-omics, the accumulation of big data is increasing at an unprecedented rate in medicine. Attendees of this year’s conference will leave with a better understanding of the direction -omics will take in the clinical trials of the present and future.
Learn firsthand from experts on how they are moving individualized medicine forward through the discovery, translation, and emerging application of omics-based clinical trials in patient care.